These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23710646)

  • 1. S100B protein may detect brain death development after severe traumatic brain injury.
    Egea-Guerrero JJ; Murillo-Cabezas F; Gordillo-Escobar E; Rodríguez-Rodríguez A; Enamorado-Enamorado J; Revuelto-Rey J; Pacheco-Sánchez M; León-Justel A; Domínguez-Roldán JM; Vilches-Arenas A
    J Neurotrauma; 2013 Oct; 30(20):1762-9. PubMed ID: 23710646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serologic behavior of S100B protein in patients who are brain dead: preliminary results.
    Egea-Guerrero JJ; Revuelto-Rey J; Gordillo-Escobar E; Rodríguez-Rodríguez A; Enamorado-Enamorado J; Ruiz de Azúa López Z; Aldabó-Pallás T; León-Justel A; Murillo-Cabezas F; Vilches-Arenas A
    Transplant Proc; 2013; 45(10):3569-72. PubMed ID: 24314961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of S100B from jugular bulb as a biomarker of poor prognosis in patients with severe acute brain injury.
    Ballesteros MA; Rubio-Lopez MI; San Martín M; Padilla A; López-Hoyos M; Llorca J; Miñambres E
    J Neurol Sci; 2018 Feb; 385():109-114. PubMed ID: 29406887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of serum copeptin and S100B protein combined with uric acid in the prognosis of children with traumatic brain injury].
    Lin L; Mai L; Chen G; Zhao E; Xue M
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):590-594. PubMed ID: 32576353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point-of-Care Platform Blood Biomarker Testing of Glial Fibrillary Acidic Protein versus S100 Calcium-Binding Protein B for Prediction of Traumatic Brain Injuries: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study.
    Okonkwo DO; Puffer RC; Puccio AM; Yuh EL; Yue JK; Diaz-Arrastia R; Korley FK; Wang KKW; Sun X; Taylor SR; Mukherjee P; Markowitz AJ; Jain S; Manley GT;
    J Neurotrauma; 2020 Dec; 37(23):2460-2467. PubMed ID: 32854584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100B is an important outcome predictor in traumatic brain injury.
    Thelin EP; Johannesson L; Nelson D; Bellander BM
    J Neurotrauma; 2013 Apr; 30(7):519-28. PubMed ID: 23297751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model predicting survival/exitus after traumatic brain injury: biomarker S100B 24h.
    Gonzćlez-Mao MC; Repáraz-Andrade A; Del Campo-Pérez V; Alvarez-García E; Vara-Perez C; Andrade-Olivié MA
    Clin Lab; 2011; 57(7-8):587-97. PubMed ID: 21888023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary peaks of S100B in serum relate to subsequent radiological pathology in traumatic brain injury.
    Thelin EP; Nelson DW; Bellander BM
    Neurocrit Care; 2014 Apr; 20(2):217-29. PubMed ID: 24146416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum S100B protein concentration in brain-dead organ donors: a pilot study.
    Krzych ŁJ; Czempik PF; Saucha W; Kokocińska D; Knapik P
    Anaesthesiol Intensive Ther; 2015; 47(4):320-3. PubMed ID: 26401738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain Injury.
    Park SH; Hwang SK
    World Neurosurg; 2018 Oct; 118():e534-e542. PubMed ID: 30257306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [GCS score combined with CT score and serum S100B protein level Can evaluate severity and early prognosis of acute traumatic brain injury].
    Yin W; Weng S; Lai S; Nie H
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Apr; 41(4):543-548. PubMed ID: 33963713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Admission S100B fails as neuro-marker but is a good predictor for intrahospital mortality in major trauma patients.
    Essl D; Schöchl H; Oberladstätter D; Lockie C; Islam M; Slezak C; Voelckel WG
    Injury; 2024 Jan; 55(1):111187. PubMed ID: 37980176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of S100B protein serum measurement in detecting intracranial injury in children with mild head trauma.
    Manzano S; Holzinger IB; Kellenberger CJ; Lacroix L; Klima-Lange D; Hersberger M; La Scala G; Altermatt S; Staubli G
    Emerg Med J; 2016 Jan; 33(1):42-6. PubMed ID: 26283067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury.
    Vos PE; Lamers KJ; Hendriks JC; van Haaren M; Beems T; Zimmerman C; van Geel W; de Reus H; Biert J; Verbeek MM
    Neurology; 2004 Apr; 62(8):1303-10. PubMed ID: 15111666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament Light.
    Al Nimer F; Thelin E; Nyström H; Dring AM; Svenningsson A; Piehl F; Nelson DW; Bellander BM
    PLoS One; 2015; 10(7):e0132177. PubMed ID: 26136237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males.
    da Rocha AB; Schneider RF; de Freitas GR; André C; Grivicich I; Zanoni C; Fossá A; Gehrke JT; Pereira Jotz G; Kaufmann M; Simon D; Regner A
    Clin Chem Lab Med; 2006; 44(10):1234-42. PubMed ID: 17032136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: results using a single (24h) time-point.
    Rainey T; Lesko M; Sacho R; Lecky F; Childs C
    Resuscitation; 2009 Mar; 80(3):341-5. PubMed ID: 19150161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome.
    Pelinka LE; Kroepfl A; Leixnering M; Buchinger W; Raabe A; Redl H
    J Neurotrauma; 2004 Nov; 21(11):1553-61. PubMed ID: 15684648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of serum markers for blood-brain barrier disruption in traumatic brain injury.
    Blyth BJ; Farhavar A; Gee C; Hawthorn B; He H; Nayak A; Stöcklein V; Bazarian JJ
    J Neurotrauma; 2009 Sep; 26(9):1497-1507. PubMed ID: 19257803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NRGN, S100B and GFAP levels are significantly increased in patients with structural lesions resulting from mild traumatic brain injuries.
    Çevik S; Özgenç MM; Güneyk A; Evran Ş; Akkaya E; Çalış F; Katar S; Soyalp C; Hanımoğlu H; Kaynar MY
    Clin Neurol Neurosurg; 2019 Aug; 183():105380. PubMed ID: 31234132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.